Author

Yin Wang

University of Maryland, BaltimoreORCID 0000-0002-4749-3768Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yin Wang5 papers · Beijing Normal University

Biology Disciplines

Click to filter author papers

Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

Yan LiuiD· 2 shared Andriy O. SamokhiniD· 1 shared Christopher Bailey· 1 shared Christopher Lazarski· 1 shared Christopher M. BaileyiD· 1 shared Chun-shu Wong· 1 shared Daniel LeeiD· 1 shared Felisa Diaz‐MendeziD· 1 shared

Activity by Year

2017-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Yan LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Myeloid HIF-1α Sustains Hypoxic Fibrotic Fronts and Drives Pulmonary Fibrosis

Yuanyi Wei, Christopher M. Bailey, Peng Zhang, Jose Herazo-Maya, Τheodoros Karampitsakos, Joseph D. Pescrille, Felisa Diaz‐Mendez, Daniel Lee, Andriy O. Samokhin, Yan Liu, Wonder P. Drake, Yin Wang

This study identifies myeloid HIF-1 as a driver of pulmonary fibrosis by sustaining hypoxic fronts and promoting fibroblast activation and matrix remodeling.

bioRxiv · Mar 11, 2026 · PreprintPathology

Treatment of Graft-versus-Host Disease by Echinomycin in a New Humanized Mouse Model

Yan Liu, Christopher Bailey, Christopher Lazarski, Chun-shu Wong, Pan Zheng, Yang Liu, Yin Wang

This study develops a new humanized GVHD model and shows that Echinomycin, a HIF1 inhibitor, reduces GVHD symptoms and extends survival in mice.

bioRxiv · Feb 16, 2017 · PreprintImmunology